Ringwood, NJ, United States of America

Elize Dekker

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Elize Dekker: Innovator in Medical Testing and Drug Market Analysis

Introduction

Elize Dekker is a prominent inventor based in Ringwood, NJ (US). She has made significant contributions to the fields of medical testing and pharmaceutical market analysis. With a total of two patents to her name, her work focuses on improving the efficiency and effectiveness of medical reporting and drug penetration strategies.

Latest Patents

Elize's latest patents include a "Method for providing medical test results" and a "Method for determining penetration opportunity of a drug into a physician market." The first patent outlines a method that selects formulary information corresponding to medical test results and generates a comprehensive medical report. The second patent provides a method for correlating laboratory test data with drug prescriptions to determine the penetration opportunity of a selected drug in the physician market.

Career Highlights

Throughout her career, Elize has worked with notable companies such as Quest Diagnostics Incorporated and Quest Diagnostics Investments, Inc. Her experience in these organizations has allowed her to develop innovative solutions that address critical challenges in the healthcare sector.

Collaborations

Elize has collaborated with esteemed professionals in her field, including T Ashok Shenoy and Niall Sweeney. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Elize Dekker's innovative work in medical testing and drug market analysis showcases her dedication to improving healthcare outcomes. Her patents reflect her commitment to advancing technology in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…